One other company i recommend looking
into is BVXV
A short description of the company:
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is Phase 3 clinical phase bio pharmaceutical company developing the M-001 Universal Flu Vaccine. M-001 is currently undergoing a pivotal, clinical efficacy, Phase 3 trial in about 12,400 participants. Results of the clinical trial are expected by the end of 2020.
M-001 is designed to provide multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic. In 7 completed clinical trials the vaccine was shown to be safe, well tolerated and immunologic to a broad range of flu strains.
More at http://www.biondvax.com/ Disclosure:
I own some 270 shares.
Since you are into bios, i think that this one has great
potential. Can you imagine the potential of a universal flu vaccine?
Influenza is not a hot subject nowadays, Corona took all
limelight, but its day will come - hopefully